Biotechnologie, Agronomie, Société et Environnement (Jan 2016)

From Valeriana officinalis to cancer therapy: the success of a bio-sourced compound

  • Hamaidia, M.,
  • Barez, PY.,
  • Carpentier, A.,
  • Lebecque, S.,
  • Miazek, K.,
  • Paul, A.,
  • Sriramareddy, SN.,
  • Staumont, B.,
  • Danthine, S.,
  • Deleu, M.,
  • Frederich, M.,
  • De Pauw, E.,
  • Delaplace, P.,
  • Delvigne, F.,
  • Goffin, D.,
  • Ongena, M.,
  • Duysinx, B.,
  • Louis, R.,
  • Cosse, JP.,
  • Willems, L.

Journal volume & issue
Vol. 20, no. s1
pp. 314 – 320

Abstract

Read online

Introduction. Over the centuries, bio-sourced compounds isolated from plants, insects and microorganisms have been a potent source of drugs for the treatment of human diseases. Literature. Bio-sourced extracts offer a wide diversity of compounds with a large number of potentially beneficial effects in humans. Serendipity has frequently played a key role in the discovery of new medicines. The canonical discovery of penicillin required both chance and a prepared mind to understand and exploit its potential for the treatment of human infections. Nowadays, most anti-cancer drugs currently in clinical use were at least partly discovered by a "fortunate happenstance". Conclusions. In this review, we recapitulate the story of one of these compounds, 2-propylpentanoic acid, derived from the Valeriana officinalis flowering plant and its path to validation as a cancer treatment.

Keywords